US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

General Anesthesia Drugs MarketThe global general anesthesia drugs market, valued at USD 4,978.1 million in 2023, is poised for steady growth, with projections indicating a compound annual growth rate ...

Hikma Pharmaceuticals Usa Inc was founded in ... substances that are used for their pharmacological properties to make medications, including antibiotics, basic vitamins, salicylic acids and ...

Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...

Also Read: Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices. “The results of the Phase 3 IMforte trial are highly encouraging and showed a statistically ...

Schizophrenia significantly shortens life expectancy by an estimated 15 years with excess mortality arising from multiple ...

Bio-Thera has previously reached a licensing and supply agreements with Pharmapark for BAT2206 with Pharmapark for exclusive rights to distribute and market the drug with a status of ... out-licensed ...

2 Non-stimulant ADHD medications of different classifications work in different ways. Both Alpha-2 adrenergic agonists and SNRIs affect norepinephrine (or noradrenaline) levels in the nervous ...

Investors will be looking to see how pharmaceuticals firm Novo Nordisk (NVO) is performing, as it faces growing competition in the weight-loss drug space. Housebuilder Vistry (VTY.L) is also due ...

Investors will be looking to see how pharmaceuticals firm Novo Nordisk (NVO) is performing, as it faces growing competition in the weight-loss drug space. Housebuilder Vistry (VTY.L) is also due to ...

Dementia treatment is more than just medication. It can include lifestyle changes, multimodal therapy, and environmental management, as well. Your dementia treatment plan will depend on underlying ...